Nano sensors has offering unprecedented precision and sensitivity in detecting and monitoring biological processes at the nanoscale. These miniature devices, typically ranging from 1 to 100 nanometers in size, exhibit unique properties that make them ideal for applications in drug development, diagnostics, and therapeutic monitoring. In the pharmaceutical industry, nano sensors play a crucial role in enhancing the understanding of cellular and molecular mechanisms, allowing for the design of more targeted and efficient drug delivery systems. These sensors can detect subtle changes in biomarkers, enabling early diagnosis of diseases and personalized treatment strategies.
Additionally, nano sensors contribute to the advancement of pharmacokinetics by providing real-time data on drug interactions within the body, optimizing dosages, and minimizing side effects. Their ability to navigate biological barriers at the molecular level opens up new possibilities for delivering drugs to specific cells or tissues. As the field of nanotechnology continues to evolve, nano sensors hold the promise of transforming the pharmaceutical landscape by providing innovative solutions for diagnosis, treatment, and monitoring of various medical conditions.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada